Ginkgo Bioworks Holdings, Inc.
- Jurisdiction
United States - ISIN
US37611X2099 (DNA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Read full profile
Stock price
Fundamentals
- Net revenue
€199.20M - Gross margin
82.2% - EBIT
-€270.41M - EBIT margin
-135.7% - Net income
-€272.02M - Net margin
-136.6%
Statement period: - (published )
Dividends
No dividend payouts
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Coen Steven P. | See remarks |
|
|
|
|
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| James Anderson |
|
|
|
Sell |